Vertex Pharmaceuticals Incorporated
METHODS OF TREATING APOL-1 DEPENDENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS

Abstract:

This application describes methods of inhibiting APOL1 and treating APOL1-mediated diseases comprising administering Compound I and/or a pharmaceutically acceptable salt thereof. ##STR00001## The application also describes pharmaceutical compositions comprising Compound I and/or a pharmaceutically acceptable salt thereof.